| 11433061 |
Heteroaryl sulfonamides and CCR2/CCR9 |
Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor T. Charvat, Wei Chen +9 more |
2022-09-06 |
$69,474,000 |
| 10532044 |
Heteroaryl sulfonamides and CCR2/CCR9 |
Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor T. Charvat, Wei Chen +9 more |
2020-01-14 |
$51,758,000 |
| 10206912 |
Heteroaryl sulfonamides and CCR2/CCR9 |
Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor T. Charvat, Wei Chen +9 more |
2019-02-19 |
$4,085,000 |
| 8093247 |
Heteroaryl sulfonamides and CCR2 |
Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor T. Charvat, Wei Chen +7 more |
2012-01-10 |
|
| 7977465 |
Peptidyl prodrugs and linkers and stabilizers useful therefor |
Howard P. Ng, Danny P. C. McGee, Guoxian Wu, Zhi-Hong Li, Sanjeev Gangwar +2 more |
2011-07-12 |
|
| RE41252 |
Peptidyl prodrugs and linkers and stabilizers useful therefor |
Howard P. Ng, Danny P. C. McGee, Guoxian Wu, Zhi-Hong Li, Sanjeev Gangwar +3 more |
2010-04-20 |
|
| 7622583 |
Heteroaryl sulfonamides and CCR2 |
Solomon Ungashe, Zheng Wei, Arindrajit Basak, Trevor T. Charvat, Wei Chen +7 more |
2009-11-24 |
|
| 7507420 |
Peptidyl prodrugs and linkers and stabilizers useful therefor |
Howard P. Ng, Danny P. C. McGee, Guoxian Wu, Zhi-Hong Li, Sanjeev Gangwar +2 more |
2009-03-24 |
$10,782,000 |
| 7087600 |
Peptidyl prodrugs and linkers and stabilizers useful therefor |
Howard P. Ng, Danny P. C. McGee, Guoxian Wu, Zhihong Li, Sanjeev Gangwar +2 more |
2006-08-08 |
$11,325,000 |
| 6951942 |
Glucocorticoid-selective anti-inflammatory agents |
Michael J. Coghlan, James P. Edwards, Steven W. Elmore, Todd K. Jones, Michael E. Kort +3 more |
2005-10-04 |
$145,413,000 |
| 6518279 |
Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
William A. Carroll, Yiyuan Chen, Irene Drizin, James F. Kerwin, Jr. |
2003-02-11 |
$99,226,000 |
| 6506766 |
Glucocortiocoid-selective antinflammatory agents |
Michael J. Coghlan, James P. Edwards, Steven W. Elmore, Todd K. Jones, Michael E. Kort +3 more |
2003-01-14 |
|
| 5756531 |
Iminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis |
Clint D. W. Brooks, Richard A. Craig, David Gunn, Teodozyji Kolasa, Andrew O. Stewart |
1998-05-26 |
$26,140,000 |
| 5514702 |
Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity |
Joseph F. Dellaria, Dee W. Brooks, Kevin J. Sallin |
1996-05-07 |
$35,965,000 |
| 5350765 |
Ether-containing inhibitors of 5-lipoxygenase |
Joseph F. Dellaria, Dee W. Brooks |
1994-09-27 |
$144,168,000 |
| 5326787 |
Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity |
Dee W. Brooks, Karen E. Rodriques |
1994-07-05 |
$19,491,000 |
| 5268379 |
Ether-containing inhibitors of 5-lipoxygenase |
Joseph F. Dellaria, Dee W. Brooks |
1993-12-07 |
$36,084,000 |
| 5214204 |
Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity |
Joseph F. Dellaria, Dee W. Brooks, Kevin J. Sallin |
1993-05-25 |
$58,893,000 |
| 4992464 |
Heteroaryl N-hydroxy amides and ureas with polar substituents as 5-lipoxygenase inhibitors |
Dee W. Brooks, James B. Summers, Karen E. Rodriques, Robert G. Maki, Joseph F. Dellaria +1 more |
1991-02-12 |
$22,233,000 |
| 4769387 |
Dibenzofuran lipoxygenase inhibiting compounds, compositions and use |
James B. Summers |
1988-09-06 |
$65,339,000 |
| 4336260 |
Method and compositions using 1-aryl-1,2,3,4-tetrahydro-.beta.-carboline-3-carboxylic acid for treating depression |
Alan J. Payne, Michael V. Aylott, Edward M. Yokley |
1982-06-22 |
$2,312,000 |
